Peginterferon beta-1a (CinnaGen)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NamePeginterferon beta-1a (CinnaGen)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionInterferon beta modulators
TargetsInterferon beta
Therapy Area/IndicationsMultiple Sclerosis, Relapsing-Remitting
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIran
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCinnagen
China Registration ClassN/A

Develop Information

Active CompaniesCinnagen
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis, Relapsing-Remitting
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A